CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 May 25

PMID 38791336

Authors

Dmitry S Karpov

Affiliations

Soon will be listed here.

Abstract

Harnessing of CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated genes) systems for detection, chemical modification, and sequence editing of nucleic acids dramatically changed many fields of fundamental science, biotechnology, and biomedicine [...].

Citing Articles

PHPGAT: predicting phage hosts based on multimodal heterogeneous knowledge graph with graph attention network.

Liu F, Zhao Z, Liu Y Brief Bioinform. 2025; 26(1.

PMID: 39833104 PMC: 11745545. DOI: 10.1093/bib/bbaf017.

Overview of Phage Defense Systems in Bacteria and Their Applications.

Xu X, Gu P Int J Mol Sci. 2025; 25(24.

PMID: 39769080 PMC: 11676413. DOI: 10.3390/ijms252413316.

Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Sosnovtseva A, Demidova N, Klimova R, Kovalev M, Kushch A, Starodubova E Int J Mol Sci. 2024; 25(22).

PMID: 39596412 PMC: 11595115. DOI: 10.3390/ijms252212346.

In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy.

Zhang W, Huang X J Hematol Oncol. 2024; 17(1):110.

PMID: 39533415 PMC: 11559219. DOI: 10.1186/s13045-024-01633-7.

References

Ding W, Zhang Y, Shi S . Development and Application of CRISPR/Cas in Microbial Biotechnology. Front Bioeng Biotechnol. 2020; 8:711. PMC: 7338305. DOI: 10.3389/fbioe.2020.00711. View

Bloomer H, Khirallah J, Li Y, Xu Q . CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells. Adv Drug Deliv Rev. 2021; 181:114087. PMC: 8844242. DOI: 10.1016/j.addr.2021.114087. View

Huang H, Lv W, Li J, Huang G, Tan Z, Hu Y . Comparison of DNA targeting CRISPR editors in human cells. Cell Biosci. 2023; 13(1):11. PMC: 9844007. DOI: 10.1186/s13578-023-00958-z. View

Takeuchi S, Yamamoto M, Matsumoto S, Kenjo E, Karashima M, Ikeda Y . Pinpoint modification strategy for stabilization of single guide RNA. J Chromatogr B Analyt Technol Biomed Life Sci. 2022; 1192:123149. DOI: 10.1016/j.jchromb.2022.123149. View

Liu M, Rehman S, Tang X, Gu K, Fan Q, Chen D . Methodologies for Improving HDR Efficiency. Front Genet. 2019; 9:691. PMC: 6338032. DOI: 10.3389/fgene.2018.00691. View

Zhang S, Shen J, Li D, Cheng Y . Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing. Theranostics. 2021; 11(2):614-648. PMC: 7738854. DOI: 10.7150/thno.47007. View

Pourcel C, Touchon M, Villeriot N, Vernadet J, Couvin D, Toffano-Nioche C . CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers. Nucleic Acids Res. 2019; 48(D1):D535-D544. PMC: 7145573. DOI: 10.1093/nar/gkz915. View

Adashi E, Gruppuso P, Cohen I . CRISPR Therapy of Sickle Cell Disease: The Dawning of the Gene Editing Era. Am J Med. 2024; 137(5):390-392. DOI: 10.1016/j.amjmed.2023.12.018. View

Odenwald M, Paul S . Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022; 28(14):1405-1429. PMC: 9048475. DOI: 10.3748/wjg.v28.i14.1405. View

10.

Mahas A, Marsic T, Masson M, Wang Q, Aman R, Zheng C . Characterization of a thermostable Cas13 enzyme for one-pot detection of SARS-CoV-2. Proc Natl Acad Sci U S A. 2022; 119(28):e2118260119. PMC: 9282225. DOI: 10.1073/pnas.2118260119. View

11.

Arroyo-Olarte R, Bravo Rodriguez R, Morales-Rios E . Genome Editing in Bacteria: CRISPR-Cas and Beyond. Microorganisms. 2021; 9(4). PMC: 8071187. DOI: 10.3390/microorganisms9040844. View

12.

Mali P, Yang L, Esvelt K, Aach J, Guell M, DiCarlo J . RNA-guided human genome engineering via Cas9. Science. 2013; 339(6121):823-6. PMC: 3712628. DOI: 10.1126/science.1232033. View

13.

Groza T, Lopez Gomez F, Haseli Mashhadi H, Munoz-Fuentes V, Gunes O, Wilson R . The International Mouse Phenotyping Consortium: comprehensive knockout phenotyping underpinning the study of human disease. Nucleic Acids Res. 2022; 51(D1):D1038-D1045. PMC: 9825559. DOI: 10.1093/nar/gkac972. View

14.

Ledford H, Callaway E . Pioneers of revolutionary CRISPR gene editing win chemistry Nobel. Nature. 2020; 586(7829):346-347. DOI: 10.1038/d41586-020-02765-9. View

15.

Niizuma K, Ogawa Y, Kogure T, Tominaga T . Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors. BMC Infect Dis. 2020; 20(1):230. PMC: 7081602. DOI: 10.1186/s12879-020-04971-2. View

16.

Cohen J . Herpesvirus latency. J Clin Invest. 2020; 130(7):3361-3369. PMC: 7324166. DOI: 10.1172/JCI136225. View

17.

Vicente M, Chaves-Ferreira M, Jorge J, Proenca J, Barreto V . The Off-Targets of Clustered Regularly Interspaced Short Palindromic Repeats Gene Editing. Front Cell Dev Biol. 2021; 9:718466. PMC: 8484971. DOI: 10.3389/fcell.2021.718466. View

18.

Xu Y, Li Z . CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J. 2020; 18:2401-2415. PMC: 7508700. DOI: 10.1016/j.csbj.2020.08.031. View

19.

Jahangir M, Zhou J, Lang B, Wang X . GABAergic System Dysfunction and Challenges in Schizophrenia Research. Front Cell Dev Biol. 2021; 9:663854. PMC: 8160111. DOI: 10.3389/fcell.2021.663854. View

20.

Razonable R . Drug-resistant cytomegalovirus: clinical implications of specific mutations. Curr Opin Organ Transplant. 2018; 23(4):388-394. DOI: 10.1097/MOT.0000000000000541. View